Search
Returning search results with filters:
Remove filter for
Category: Drugs
Remove filter for
Last updated: 2019
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2019
- December 201913 results available
- November 201911 results available
- October 201919 results available
- September 201917 results available
- August 201913 results available
- July 201915 results available
- June 201914 results available
- May 20197 results available
- April 201913 results available
- March 201915 results available
- February 20197 results available
- January 20196 results available
Recall class
Displaying 46 - 60 of 150 items.
Apotex Inc Ranitidine Product Recall (2019-09-24)
RecallHealth product recall | 2019-09-24
Pro Doc Limitee Ranitidine Product Recall (2019-09-24)
RecallHealth product recall | 2019-09-24
Sanis Health Inc. Ranitidine Product Recall (2019-09-24)
RecallHealth product recall | 2019-09-24
Baxter Canada product recall (2019-09-23)
RecallHealth product recall | 2019-09-23
Lemon Lightening Serum (2019-09-23)
RecallHealth product recall | 2019-09-23
LMD 10% IN DEXTROSE 5% (2019-09-23)
RecallHealth product recall | 2019-09-23
Revlon Canada Product Recall (2019-09-18)
RecallHealth product recall | 2019-09-18
Unauthorized products may pose serious health risks (August 12, 2019 to September 18, 2019)
AlertPublic advisory | 2019-09-18
Yunnan Baiyao Toothpaste (2019-09-18)
RecallHealth product recall | 2019-09-18
Health Canada advises Canadians to exercise caution when taking gabapentin or pregabalin with opioids
AlertInformation update | 2019-09-17
Sandoz Canada Ranitidine Product Recall (2019-09-17)
RecallHealth product recall | 2019-09-17
Safetec Triple Antibiotic Ointment (2019-09-16)
RecallHealth product recall | 2019-09-16
Health Canada assessing NDMA in ranitidine
AlertInformation update | 2019-09-13
Xolair (2019-09-06)
RecallHealth product recall | 2019-09-06
Health Canada seized unauthorized Bielenda Dr. Medica anti-acne products because they may pose serious health risks
AlertPublic advisory | 2019-09-03